Table 1 Descriptive statistics for the TCGA cohort according to recurrence outcome and tumor grade
From: A deep learning model to predict glioma recurrence using integrated genomic and clinical data
|  | Late glioma recurrence (TTR ≥ 390 days) | Early glioma recurrence (TTR < 390 days) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Â | Tumor grade (n) | All (109) | II (52) | III (52) | IV (5) | All (82) | II (21) | III (36) | IV (25) |
Sex [n] | Male | 58 | 28 | 28 | 2 | 49 | 10 | 22 | 17 |
Female | 51 | 24 | 24 | 3 | 33 | 11 | 14 | 8 | |
Race [n]a | White | 102 | 48 | 49 | 5 | 74 | 18 | 35 | 21 |
African American or Black | 5 | 2 | 3 | 0 | 5 | 2 | 1 | 2 | |
American Indian or Alaska Native | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
Asian | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 1 | |
Hispanic or Latino [n]a | No | 95 | 40 | 50 | 5 | 77 | 20 | 35 | 22 |
Yes | 4 | 4 | 0 | 0 | 1 | 0 | 1 | 0 | |
Histology [n]b | Astrocytoma | 57 | 35 | 22 | 0 | 24 | 13 | 11 | 0 |
Glioblastoma | 24 | 3 | 16 | 5 | 42 | 4 | 13 | 25 | |
Oligodendroglioma | 24 | 14 | 10 | 0 | 9 | 2 | 7 | 0 | |
Astrocytoma wildtype | 4 | 0 | 4 | 0 | 7 | 2 | 5 | 0 | |
IDH & 1p19q codeletion status [n] | IDH-mutant, non-codeleted | 57 | 35 | 22 | 0 | 24 | 13 | 11 | 0 |
IDH-wildtype | 28 | 3 | 20 | 5 | 49 | 6 | 18 | 25 | |
IDH-mutant, codeleted | 24 | 14 | 10 | 0 | 9 | 2 | 7 | 0 | |
Vital status [n] | Deceased | 56 | 18 | 34 | 4 | 56 | 9 | 25 | 22 |
Alive | 53 | 34 | 18 | 1 | 26 | 12 | 11 | 3 | |
Days to recurrence | Median | 809.0 | 869.0 | 690.5 | 566.0 | 202.5 | 265.0 | 196.5 | 176.0 |
IQR | 698.0 | 664.5 | 694.3 | 293.0 | 164.0 | 160.0 | 166.5 | 161.0 | |
Age [yr] | Median | 41.0 | 35.0 | 45.0 | 63.0 | 52.5 | 41.0 | 52.5 | 57.0 |
IQR | 19.0 | 11.0 | 20.3 | 1.0 | 19.0 | 23.0 | 20.0 | 10.0 | |
